Integer (NYSE:ITGR) Sees Strong Trading Volume – Still a Buy?

Integer Holdings Co. (NYSE:ITGR) shares saw an uptick in trading volume on Monday . 225,325 shares traded hands during trading, a decline of 24% from the previous session’s volume of 296,848 shares.The stock last traded at $120.69 and had previously closed at $121.96.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Oppenheimer downgraded shares of Integer from an “outperform” rating to a “market perform” rating in a research note on Friday, February 21st. Wells Fargo & Company restated an “overweight” rating and set a $160.00 target price on shares of Integer in a research report on Tuesday, December 3rd. Benchmark raised their target price on shares of Integer from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Friday, February 21st. Truist Financial boosted their price target on Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Finally, KeyCorp raised their price objective on Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Two equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $147.67.

Integer Stock Performance

The stock has a fifty day simple moving average of $135.47 and a two-hundred day simple moving average of $133.01. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. The stock has a market cap of $4.08 billion, a price-to-earnings ratio of 36.12, a P/E/G ratio of 1.72 and a beta of 1.24.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing the consensus estimate of $1.46 by ($0.03). The business had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. Analysts expect that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Institutional Trading of Integer

Hedge funds and other institutional investors have recently modified their holdings of the stock. Mather Group LLC. lifted its stake in shares of Integer by 304.3% in the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 143 shares during the last quarter. Lee Danner & Bass Inc. bought a new position in Integer in the fourth quarter valued at about $27,000. Huntington National Bank raised its position in Integer by 8,933.3% in the third quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after purchasing an additional 268 shares during the last quarter. R Squared Ltd acquired a new stake in shares of Integer during the fourth quarter valued at about $44,000. Finally, Sterling Capital Management LLC grew its holdings in shares of Integer by 472.9% during the fourth quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider’s stock worth $45,000 after purchasing an additional 279 shares during the last quarter. Institutional investors own 99.29% of the company’s stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.